• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

光动力疗法治疗结节性硬化症相关面部血管纤维瘤患者。

Photodynamic therapy in a patient with facial angiofibromas due to tuberous sclerosis complex.

机构信息

Department of Dermatology and Venereology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.

Department of Dermatology and Venereology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.

出版信息

Photodiagnosis Photodyn Ther. 2019 Dec;28:183-185. doi: 10.1016/j.pdpdt.2019.08.009. Epub 2019 Aug 6.

DOI:10.1016/j.pdpdt.2019.08.009
PMID:31398516
Abstract

The facial angiofbromas due to tuberous sclerosis complex produced significant social and emotional distress for affected individuals, but there is no specific therapeutic strategy up to now. Herein, we report a case of facial angiofibromas successfully treated by 5-aminolaevulinic acid-mediated photodynamic therapy (ALA-PDT) with no recurrence for 6 years, thus providing a promising therapeutic option.

摘要

结节性硬化症相关的面部血管纤维瘤会给患者带来显著的社交和情绪困扰，但目前尚无特定的治疗策略。在此，我们报告了一例成功接受 5-氨基酮戊酸介导的光动力疗法（ALA-PDT）治疗的面部血管纤维瘤病例，6 年无复发，为治疗提供了一种有前景的选择。

相似文献

1
Photodynamic therapy in a patient with facial angiofibromas due to tuberous sclerosis complex.光动力疗法治疗结节性硬化症相关面部血管纤维瘤患者。
Photodiagnosis Photodyn Ther. 2019 Dec;28:183-185. doi: 10.1016/j.pdpdt.2019.08.009. Epub 2019 Aug 6.
2
The combination of photodynamic therapy and ultrapulse carbon dioxide laser for facial angiofibromas in tuberous sclerosis complex: A case report.光动力疗法联合超脉冲二氧化碳激光治疗结节性硬化症面部血管纤维瘤 1 例报告。
Photodiagnosis Photodyn Ther. 2022 Mar;37:102725. doi: 10.1016/j.pdpdt.2022.102725. Epub 2022 Jan 15.
3
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial.局部他莫昔芬治疗结节性硬化症相关面血管纤维瘤的疗效和安全性：一项 TREATMENT 随机临床试验。
JAMA Dermatol. 2018 Jul 1;154(7):773-780. doi: 10.1001/jamadermatol.2018.0464.
4
Treatment of angiofibromas of tuberous sclerosis with 5-aminolevulinic acid blue light photodynamic therapy followed by immediate pulsed dye laser.采用5-氨基酮戊酸蓝光光动力疗法治疗结节性硬化症的血管纤维瘤，随后立即进行脉冲染料激光治疗。
Dermatol Surg. 2009 Nov;35(11):1849-51. doi: 10.1111/j.1524-4725.2009.01304.x. Epub 2009 Aug 13.
5
Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.外用雷帕霉素：治疗结节性硬化症面部血管纤维瘤的新方法。
Arch Dermatol. 2010 Jul;146(7):715-8. doi: 10.1001/archdermatol.2010.125.
6
A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.一种用于治疗结节性硬化症面部血管纤维瘤的新型外用雷帕霉素乳膏。
J Child Neurol. 2013 Jul;28(7):933-6. doi: 10.1177/0883073813488664. Epub 2013 May 16.
7
Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.西罗莫司凝胶治疗与安慰剂治疗结节性硬化症患者面部血管纤维瘤：一项随机临床试验。
JAMA Dermatol. 2018 Jul 1;154(7):781-788. doi: 10.1001/jamadermatol.2018.1408.
8
[Facial angiofibromas associated to tuberous sclerosis treated with topical sirolimus].[外用西罗莫司治疗与结节性硬化症相关的面部血管纤维瘤]
Ugeskr Laeger. 2013 Oct 21;175(43):2569-70.
9
Comparative Effects of Topical 0.2% Sirolimus for Angiofibromas in Adults and Pediatric Patients with Tuberous Sclerosis Complex.成人与结节性硬化症伴发的青少年血管纤维瘤患者中局部使用 0.2%西罗莫司的疗效比较。
Dermatology. 2018;234(1-2):13-22. doi: 10.1159/000489089. Epub 2018 Jun 20.
10
The Efficacy of Everolimus for Facial Angiofibromas in Tuberous Sclerosis Complex Patients Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma.依维莫司治疗结节性硬化症患者肾血管平滑肌脂肪瘤/室管膜下巨细胞星形细胞瘤相关面部血管纤维瘤的疗效。
Dermatology. 2021;237(3):444-449. doi: 10.1159/000510222. Epub 2020 Oct 8.